SSA
ENTL

Schonfeld Strategic Advisors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20,000
Closed -$276K – 873
2017
Q1 		$276K Buy
+20,000
New +$321K 0.03% 484

Other funds holding ENTL

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schonfeld Strategic Advisors's ENTL Position: Q2 2017 in Review

Schonfeld Strategic Advisors sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q2 2017, closing a stake of 20,000 shares — an estimated $276K sold.

Schonfeld Strategic Advisors first reported a position in ENTL in Q1 2017 and held it in 1 quarter. The position peaked at $276K in Q1 2017. 73 funds tracked by Wall St. Rank hold ENTL as of Q2 2017.

  • Schonfeld Strategic Advisors reported no remaining Entellus Medical, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 20,000 Entellus Medical, Inc. Common Stock shares in Q2 2017, an estimated $276K.
  • Schonfeld Strategic Advisors first reported a position in Entellus Medical, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Entellus Medical, Inc. Common Stock position peaked at $276K in Q1 2017.
  • 73 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q2 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.